Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers

被引：0
|
作者：
Chapin, William Joseph [1 ]
Agarwal, Parul [1 ]
DiCicco, Lisa [1 ]
Palmer, Rayleigh [1 ]
Cenou, Nadia [1 ]
Huang, Alexander Chan Chi [1 ]
Karasic, Thomas Benjamin [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4184
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers
    Den Linger, Crystal S.
    Meropol, Neal J.
    Li, Tianyu
    Lewis, Nancy L.
    Engstrom, Paul F.
    Weiner, Louis M.
    Cheng, Jonathan D.
    Alpaugh, R. Katherine
    Cooper, Harry
    Wright, John J.
    Cohen, Steven J.
    CLINICAL COLORECTAL CANCER, 2014, 13 (02) : 81 - 86
  • [2] Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
    Bengala, C.
    Bertolini, F.
    Malavasi, N.
    Boni, C.
    Aitini, E.
    Dealis, C.
    Zironi, S.
    Depenni, R.
    Fontana, A.
    Del Giovane, C.
    Luppi, G.
    Conte, P.
    BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 68 - 72
  • [3] Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
    C Bengala
    F Bertolini
    N Malavasi
    C Boni
    E Aitini
    C Dealis
    S Zironi
    R Depenni
    A Fontana
    C Del Giovane
    G Luppi
    P Conte
    British Journal of Cancer, 2010, 102 : 68 - 72
  • [4] Randomized, multicenter phase II trial of CAP7.1 in patients with advanced biliary tract cancers.
    Pape, Ulrich-Frank
    Kasper, Stefan
    Sinn, Marianne
    Caca, Karel
    Kuhlmann, Jan
    Keilholz, Ulrich
    Vogel, Arndt
    Utku, Nalan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] PRELIMINARY CLINICAL EXPERIENCE WITH XMAB20717, A PD-1 X CTLA-4 BISPECIFIC ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS
    Shum, Elaine
    Reilley, Matthew
    Najjar, Yana
    Daud, Adil
    Thompson, John
    Baranda, Joaquina
    Harvey, R. Donald
    Shields, Anthony
    Cohen, Ezra
    Pant, Shubham
    Leidner, Rom
    Mita, Alain
    Cohen, Roger
    Chmielowski, Bartosz
    Stein, Mark
    Hu-Lieskovan, Siwen
    Fleener, Catherine
    Ding, Ying
    Bao, Lei
    Chollate, Sowmya
    Shorr, Jolene
    Clynes, Raphael
    Hickingbottom, Barbara
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A553 - A553
  • [6] A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC).
    Kim, Richard D.
    Kim, Dae Won
    Alese, Olatunji B.
    Li, Daneng
    Shah, Neal
    Schell, Michael J.
    Zhou, Jun Min
    Chung, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Phase II Trial of FOLFIRINOX in Advanced Biliary Tract Cancer
    Bazarbashi, Shouki
    Aseafan, Mohamed
    Elshenawy, Mahmoud
    Alzahrani, Ahmed
    Aljubran, Ali H.
    Almugbel, Fahad
    Alzannan, Noura
    Elhassan, Tusneem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [8] Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma
    Chakrabarti, Sakti
    Zemla, Tyler J.
    Ahn, Daniel H.
    Ou, Fang-Shu
    Fruth, Briant
    Borad, Mitesh J.
    Hartgers, Mindy L.
    Wessling, Jaclynn
    Walkes, Rachel L.
    Alberts, Steven R.
    McWilliams, Robert R.
    Liu, Minetta C.
    Durgin, Lori M.
    Bekaii-Saab, Tanios S.
    Mahipal, Amit
    ONCOLOGIST, 2020, 25 (05): : 380 - +
  • [9] Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
    Afshin Dowlati
    James Posey
    Ramesh K. Ramanathan
    Linda Rath
    Pingfu Fu
    Amitabh Chak
    Smitha Krishnamurthi
    Joanna Brell
    Stephen Ingalls
    Charles L. Hoppel
    Percy Ivy
    Scot C. Remick
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 73 - 78
  • [10] Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
    Dowlati, Afshin
    Posey, James
    Ramanathan, Ramesh K.
    Rath, Linda
    Fu, Pingfu
    Chak, Amitabh
    Krishnamurthi, Smitha
    Brell, Joanna
    Ingalls, Stephen
    Hoppel, Charles L.
    Ivy, Percy
    Remick, Scot C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 73 - 78
12345